Condition

Grade 3a Follicular Lymphoma clinical trials and research

• 6Clinical trials
• 2Countries

Newest Grade 3a Follicular Lymphoma clinical trials

All recruiting trials (6)

• Tafasitamab and Rituximab for newly diagnosed follicular lymphoma

  This study tests a combination of tafasitamab and rituximab to treat adults with newly diagnosed follicular lymphoma.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT07731789

• Pirtobrutinib plus Mosunetuzumab for relapsed or refractory grade 1–3a follicular lymphoma

  This trial tests whether giving pirtobrutinib together with mosunetuzumab can better treat adults with relapsed or refractory grade 1–3a follicular lymphoma.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT06948786

• Combining three medications for untreated follicular lymphoma

  This study is testing a new combination of three medications to see if they can effectively treat people with untreated follicular lymphoma without using traditional chemotherapy.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT06471738

• Low dose mosunetuzumab treatment for indolent B-cell lymphoma

  This study is testing a new low-dose treatment called mosunetuzumab to see if it can help people with indolent B-cell lymphoma by slowing down or stopping the growth of their cancer.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT06442475

• Combining acalabrutinib and obinutuzumab to treat untreated follicular lymphoma and indolent non-Hodgkin lymphomas

  This study is testing if combining two treatments, acalabrutinib and obinutuzumab, can help people with untreated follicular lymphoma and other slow-growing non-Hodgkin lymphomas feel better and improve their quality of life.

  Recruiting Phase 2 Emory University · Atlanta, Georgia · NCT04883437

• Acalabrutinib, Lenalidomide, and Rituximab for Advanced Follicular Lymphoma

  This phase 2 trial tests whether the combination of acalabrutinib, lenalidomide, and rituximab can control CD20-positive stage III–IV follicular lymphoma in patients who have not yet had systemic lymphoma treatment.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT04404088

Related topics

Quick answers

How many Grade 3a Follicular Lymphoma clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (5 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 6. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →